
NEWSMAX @NEWSMAX
Eli Lilly and Co. will cut list prices by 70% for its most commonly prescribed forms of insulin, Humalog and Humulin, beginning in the fourth quarter of this year, the drugmaker said on Wednesday. https://t.co/HO4Cv3pN1N — PolitiTweet.org